{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:52:49Z","timestamp":1793145169832,"version":"4.5.0"},"reference-count":155,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"German Research Society (DFG)","award":["CRC1279"],"award-info":[{"award-number":["CRC1279"]}]},{"name":"German Research Society (DFG)","award":["1160914"],"award-info":[{"award-number":["1160914"]}]},{"name":"Alexander von Humboldt-Stiftung","award":["CRC1279"],"award-info":[{"award-number":["CRC1279"]}]},{"name":"Alexander von Humboldt-Stiftung","award":["1160914"],"award-info":[{"award-number":["1160914"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Expanding the antifungal drug arsenal for treating Candida infections is crucial in this era of the rising life expectancy of patients with immunosuppression and comorbidities. Infections caused by Candida species are on the rise, including those caused by multidrug-resistant strains or species, and the list of antifungals approved for the treatment of these infections is still limited. Antimicrobial peptides (AMPs) are short cationic polypeptides whose antimicrobial activity is under intense investigation. In this review, we present a comprehensive summary of the AMPs with anti-Candida activity that have undergone successful preclinical or clinical trials. Their source, mode of action, and animal model of infection (or clinical trial) are presented. In addition, as some of these AMPs have been tested in combination therapy, the advantages of this approach, as well as the studied cases that have used AMPs and other drugs concomitantly to fight Candida infections, are described.<\/jats:p>","DOI":"10.3390\/pharmaceutics15030789","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T03:29:46Z","timestamp":1677554986000},"page":"789","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Antimicrobial Peptides: Avant-Garde Antifungal Agents to Fight against Medically Important Candida Species"],"prefix":"10.3390","volume":"15","author":[{"given":"Gina P.","family":"Rodr\u00edguez-Casta\u00f1o","sequence":"first","affiliation":[{"name":"Studies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, School of Medicine and Health Sciences, Universidad de Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9297-6419","authenticated-orcid":false,"given":"Frank","family":"Rosenau","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Biotechnology, Ulm University, 89081 Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8436-4260","authenticated-orcid":false,"given":"Ludger","family":"St\u00e4ndker","sequence":"additional","affiliation":[{"name":"Core Facility for Functional Peptidomics, Faculty of Medicine, Ulm University, 89081 Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7547-5172","authenticated-orcid":false,"given":"Carolina","family":"Firacative","sequence":"additional","affiliation":[{"name":"Studies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, School of Medicine and Health Sciences, Universidad de Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mib.2020.05.006","article-title":"The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine","volume":"56","author":"Kumamoto","year":"2020","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.micres.2013.02.008","article-title":"Disruption of the intestinal mucosal barrier in Candida albicans infections","volume":"168","author":"Yan","year":"2013","journal-title":"Microbiol. Res."},{"key":"ref_3","unstructured":"Murray, P.R., Bach, E.J., Jorgensen, J.H., Pfaller, M.A., and Landry, M.L. (2007). Manual of Clinical Microbiology, ASM Press. [9th ed.]."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1128\/JCM.37.9.2817-2828.1999","article-title":"Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3","volume":"37","author":"Marco","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12275-016-5514-0","article-title":"Interaction of Candida albicans with host cells: Virulence factors, host defense, escape strategies, and the microbiota","volume":"54","author":"Mogavero","year":"2016","journal-title":"J. Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Calderone, R.A., and Clancy, C.J. (2011). Candida and Candidiasis, American Society for Microbiology Press.","DOI":"10.1128\/9781555817176"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s12257-018-0477-0","article-title":"Invasive Fungal Infections and Their Epidemiology: Measures in the Clinical Scenario","volume":"24","author":"Bajpai","year":"2019","journal-title":"Biotechnol. Bioprocess Eng."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e200430","DOI":"10.1590\/0074-02760200430","article-title":"Invasive fungal disease in humans: Are we aware of the real impact?","volume":"115","author":"Firacative","year":"2020","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: Human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bongomin, F., Gago, S., Oladele, R.O., and Denning, D.W. (2017). Global and multi-national prevalence of fungal diseases-estimate precision. J. Fungi, 3.","DOI":"10.3390\/jof3040057"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1128\/JCM.43.12.5848-5859.2005","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study: A 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing","volume":"43","author":"Pfaller","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1348-0421.2008.00083.x","article-title":"Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital","volume":"53","author":"Satoh","year":"2009","journal-title":"Microbiol. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jac\/dkg117","article-title":"Caspofungin: The first representative of a new antifungal class","volume":"51","author":"Herbrecht","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nchembio.1496","article-title":"Amphotericin forms an extramembranous and fungicidal sterol sponge","volume":"10","author":"Anderson","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s11745-008-3225-y","article-title":"CYP51: A major drug target in the cytochrome P450 superfamily","volume":"43","author":"Lepesheva","year":"2008","journal-title":"Lipids"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1586\/14787210.2015.1032939","article-title":"Azole antifungals: 35 years of invasive fungal infection management","volume":"13","author":"Allen","year":"2015","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1073\/pnas.1115361109","article-title":"Mismatch repair-dependent mutagenesis in nondividing cells","volume":"109","author":"Rodriguez","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_19","unstructured":"CDC (2022, September 29). 2019 AR Threats Report, Available online: https:\/\/www.cdc.gov\/drugresistance\/biggest-threats.html#candida."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/AAC.00683-11","article-title":"Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo","volume":"56","author":"Lee","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e02299-17","DOI":"10.1128\/AAC.02299-17","article-title":"FKS2 and FKS3 Genes of Opportunistic Human Pathogen Candida albicans Influence Echinocandin Susceptibility","volume":"62","author":"Suwunnakorn","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","article-title":"Resistance of Candida to azoles and echinocandins worldwide","volume":"25","author":"Pristov","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/AAC.03470-14","article-title":"Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans","volume":"59","author":"Flowers","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1128\/JCM.02117-09","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: A 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion","volume":"48","author":"Pfaller","year":"2010","journal-title":"J. Clin. Microbiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.15585\/mmwr.mm6901a2","article-title":"Candida auris Isolates Resistant to Three Classes of Antifungal Medications\u2014New York, 2019","volume":"69","author":"Ostrowsky","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0966-842X(00)01823-0","article-title":"The role of cationic antimicrobial peptides in innate host defences","volume":"8","author":"Hancock","year":"2000","journal-title":"Trends Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","article-title":"APD3: The antimicrobial peptide database as a tool for research and education","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0005-2736(99)00197-2","article-title":"Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes","volume":"1462","author":"Matsuzaki","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1021\/bi034514x","article-title":"Analysis of membrane-binding properties of dermaseptin analogues: Relationships between binding and cytotoxicity","volume":"42","author":"Gaidukov","year":"2003","journal-title":"Biochemistry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.bbamem.2006.02.009","article-title":"Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides","volume":"1758","author":"Straus","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1074\/jbc.M504327200","article-title":"Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action","volume":"281","author":"Rosenfeld","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","article-title":"Antimicrobial peptides of multicellular organisms","volume":"415","author":"Zasloff","year":"2002","journal-title":"Nature"},{"key":"ref_33","unstructured":"Wang, G. (2017). Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies, CABI. [2nd ed.]."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2958.2008.06563.x","article-title":"Adaptation of the bacterial membrane to changing environments using aminoacylated phospholipids","volume":"71","author":"Roy","year":"2009","journal-title":"Mol. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1534\/g3.115.023622","article-title":"Genomic Signatures of Experimental Adaptation to Antimicrobial Peptides in Staphylococcus aureus","volume":"6","author":"Johnston","year":"2016","journal-title":"G3"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ibmb.2019.04.017","article-title":"In vivo exposure of insect AMP resistant Staphylococcus aureus to an insect immune system","volume":"110","author":"Urbanski","year":"2019","journal-title":"Insect Biochem. Mol. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10989-014-9430-z","article-title":"Cationic Antimicrobial Peptides Cytotoxicity on Mammalian Cells: An Analysis Using Therapeutic Index Integrative Concept","volume":"21","author":"Bacalum","year":"2015","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.mycmed.2018.07.009","article-title":"Synthesis, characterization and antifungal activity of a novel formulated nanocomposite containing Indolicidin and Graphene oxide against disseminated candidiasis","volume":"28","author":"Farzanegan","year":"2018","journal-title":"J. Mycol. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1086\/522427","article-title":"Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection","volume":"196","author":"Lupetti","year":"2007","journal-title":"J. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10989-022-10368-3","article-title":"Antifungal Peptide CGA-N9 Protects Against Systemic Candidiasis in Mice","volume":"28","author":"Li","year":"2022","journal-title":"Int. J. Pept. Res. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.3892\/etm.2017.4290","article-title":"Protective effect of a novel antifungal peptide derived from human chromogranin a on the immunity of mice infected with Candida krusei","volume":"13","author":"Li","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1080\/21655979.2021.2017680","article-title":"Inhibition of Candida albicans in vivo and in vitro by antimicrobial peptides chromogranin A-N12 through microRNA-155\/suppressor of cytokine signaling 1 axis","volume":"13","author":"Li","year":"2022","journal-title":"Bioengineered"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00726-017-2507-1","article-title":"The in vitro, in vivo antifungal activity and the action mode of Jelleine-I against Candida species","volume":"50","author":"Jia","year":"2018","journal-title":"Amino Acids"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1128\/AAC.00448-08","article-title":"In vitro activity of the antifungal plant defensin RsAFP2 against Candida isolates and its in vivo efficacy in prophylactic murine models of candidiasis","volume":"52","author":"Tavares","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rossi, D.C., Munoz, J.E., Carvalho, D.D., Belmonte, R., Faintuch, B., Borelli, P., Miranda, A., Taborda, C.P., and Daffre, S. (2012). Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis. BMC Microbiol., 12.","DOI":"10.1186\/1471-2180-12-28"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.peptides.2003.08.021","article-title":"Prevention of lethal murine candidiasis using HP (2-20), an antimicrobial peptide derived from the N-terminus of Helicobacter pylori ribosomal protein L1","volume":"24","author":"Ribeiro","year":"2003","journal-title":"Peptides"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"ftx072","DOI":"10.1093\/femspd\/ftx072","article-title":"Efficacy of Histatin5 in a murine model of vulvovaginal candidiasis caused by Candida albicans","volume":"75","author":"Liao","year":"2017","journal-title":"Pathog. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/1348-0421.12538","article-title":"Lasioglossins LLIII affect the morphogenesis of Candida albicans and reduces the duration of experimental vaginal candidiasis in mice","volume":"61","author":"Vrablikova","year":"2017","journal-title":"Microbiol. Immunol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.2147\/IDR.S218778","article-title":"Functional synergy of antimicrobial peptides and chlorhexidine acetate against Gram-negative\/Gram-positive bacteria and a fungus in vitro and in vivo","volume":"12","author":"Zhu","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e0234520","DOI":"10.1128\/AAC.02345-20","article-title":"Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal Activity","volume":"65","author":"Duncan","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1747-0285.2006.00333.x","article-title":"Antifungal activity of human salivary mucin-derived peptide, MUC7 12-mer, in a murine model of oral candidiasis","volume":"66","author":"Muralidharan","year":"2005","journal-title":"J. Pept. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e00210-20","DOI":"10.1128\/AAC.00210-20","article-title":"Chemokine CCL28 Is a Potent Therapeutic Agent for Oropharyngeal Candidiasis","volume":"64","author":"He","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_53","first-page":"33","article-title":"Condition for effective inhibition of Candida albicans growth by lactoferricin B and its therapeutic activity with fluconazole against oral candidiasis in mice","volume":"2","author":"Tanaka","year":"2011","journal-title":"Med. Mycol. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"fow099","DOI":"10.1093\/femsyr\/fow099","article-title":"Antifungal activity in vitro and in vivo of a salmon protamine peptide and its derived cyclic peptide against Candida albicans","volume":"17","author":"Nagao","year":"2017","journal-title":"FEMS Yeast Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jac\/dks513","article-title":"Therapeutic efficacy of halocidin-derived peptide HG1 in a mouse model of Candida albicans oral infection","volume":"68","author":"Shin","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Gong, Y., Li, H., Wu, F., Li, Y., and Zhang, S. (2022). Fungicidal Activity of AP10W, a Short Peptide Derived from AP-2 Complex Subunit mu-A, In Vitro and In Vivo. Biomolecules, 12.","DOI":"10.3390\/biom12070965"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"862834","DOI":"10.3389\/fmicb.2022.862834","article-title":"In vitro and in vivo Activity of Phibilin Against Candida albicans","volume":"13","author":"Li","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Song, C., Wen, R., Zhou, J., Zeng, X., Kou, Z., Zhang, J., Wang, T., Chang, P., Lv, Y., and Wu, R. (2022). Antibacterial and Antifungal Properties of a Novel Antimicrobial Peptide GK-19 and Its Application in Skin and Soft Tissue Infections Induced by MRSA or Candida albicans. Pharmaceutics, 14.","DOI":"10.22541\/au.165115643.37740112\/v1"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Tsai, P.W., Yang, C.Y., Chang, H.T., and Lan, C.Y. (2011). Human antimicrobial peptide LL-37 inhibits adhesion of Candida albicans by interacting with yeast cell-wall carbohydrates. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017755"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000330855","article-title":"Efficacy of CG(3)R(6)TAT nanoparticles self-assembled from a novel antimicrobial peptide for the treatment of Candida albicans meningitis in rabbits","volume":"57","author":"Xu","year":"2011","journal-title":"Chemotherapy"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1600777","DOI":"10.1002\/adhm.201600777","article-title":"Short Synthetic alpha-Helical-Forming Peptide Amphiphiles for Fungal Keratitis Treatment In Vivo","volume":"6","author":"Wu","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"16905","DOI":"10.1038\/s41598-019-53402-z","article-title":"Rhesus Theta Defensin 1 Promotes Long Term Survival in Systemic Candidiasis by Host Directed Mechanisms","volume":"9","author":"Basso","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamem.2014.11.024","article-title":"Fungicidal mechanisms of the antimicrobial peptide Bac8c","volume":"1848","author":"Lee","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/infdis\/jix062","article-title":"Eradication of Staphylococcus aureus Biofilm Infections Using Synthetic Antimicrobial Peptides","volume":"215","author":"Zapotoczna","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_65","first-page":"1495","article-title":"The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans","volume":"387","author":"Veerman","year":"2006","journal-title":"Biol. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12275-014-3630-2","article-title":"Responses of Candida albicans to the human antimicrobial peptide LL-37","volume":"52","author":"Tsai","year":"2014","journal-title":"J. Microbiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/psc.2552","article-title":"Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity","volume":"19","author":"Jacob","year":"2013","journal-title":"J. Pept. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejmech.2017.05.028","article-title":"LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity","volume":"136","author":"Kim","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/08927014.2017.1370087","article-title":"KR-12-a5 is a non-cytotoxic agent with potent antimicrobial effects against oral pathogens","volume":"33","author":"Caiaffa","year":"2017","journal-title":"Biofouling"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fphar.2019.00639","article-title":"KR-12-a5 Reverses Adverse Effects of Lipopolysaccharides on HBMSC Osteogenic Differentiation by Influencing BMP\/Smad and P38 MAPK Signaling Pathways","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.dci.2007.03.007","article-title":"Canine cathelicidin (K9CATH): Gene cloning, expression, and biochemical activity of a novel pro-myeloid antimicrobial peptide","volume":"31","author":"Sang","year":"2007","journal-title":"Dev. Comp. Immuno.l"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"279","DOI":"10.56808\/2985-1130.2833","article-title":"Evaluation of antimicrobial peptide K9CATH in a murine model of mastitis","volume":"47","author":"Melgarejo","year":"2017","journal-title":"Thai J. Vet. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.5897\/AJMR12.1208","article-title":"Evaluation of the K9CATH peptide in the treatment of experimental pulmonary tuberculosis","volume":"6","author":"Melgarejo","year":"2012","journal-title":"Afr. J. Microbiol. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1021\/acs.jmedchem.5b01264","article-title":"A Designed Tryptophan- and Lysine\/Arginine-Rich Antimicrobial Peptide with Therapeutic Potential for Clinical Antibiotic-Resistant Candida albicans Vaginitis","volume":"59","author":"Jin","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"19298","DOI":"10.1074\/jbc.271.32.19298","article-title":"Mode of action of the antimicrobial peptide indolicidin","volume":"271","author":"Falla","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0006-3495(97)78713-7","article-title":"Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids","volume":"72","author":"Ladokhin","year":"1997","journal-title":"Biophys. J."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6968.1998.tb12896.x","article-title":"Mechanism of antimicrobial action of indolicidin","volume":"160","author":"Subbalakshmi","year":"1998","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/jac\/dkn074","article-title":"Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections","volume":"61","author":"Fritsche","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/IAI.69.3.1469-1476.2001","article-title":"Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria","volume":"69","author":"Nibbering","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1021\/ja0780380","article-title":"On the nature of antimicrobial activity: A model for protegrin-1 pores","volume":"130","author":"Langham","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/IAI.66.6.2486-2493.1998","article-title":"Activity of protegrins against yeast-phase Candida albicans","volume":"66","author":"Cho","year":"1998","journal-title":"Infect. Immun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11240-013-0344-9","article-title":"Transient expression and characterization of the antimicrobial peptide protegrin-1 in Nicotiana tabacum for control of bacterial and fungal mammalian pathogens","volume":"115","author":"Korban","year":"2013","journal-title":"Plant Cell Tissue Organ Cult."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00003246-200301000-00034","article-title":"Protegrin-1 increases bacterial clearance in sepsis but decreases survival","volume":"31","author":"Steinstraesser","year":"2003","journal-title":"Crit. Care Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1128\/AAC.41.8.1738","article-title":"Protegrin-1: A broad-spectrum, rapidly microbicidal peptide with in vivo activity","volume":"41","author":"Steinberg","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0360-3016(03)01627-4","article-title":"A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy","volume":"58","author":"Trotti","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/1042819031000079159","article-title":"A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)","volume":"44","author":"Giles","year":"2003","journal-title":"Leuk. Lymphoma"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1128\/iai.59.8.2549-2554.1991","article-title":"Anticandidal activity of major human salivary histatins","volume":"59","author":"Xu","year":"1991","journal-title":"Infect. Immun."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/EC.00095-14","article-title":"How does it kill?: Understanding the candidacidal mechanism of salivary histatin 5","volume":"13","author":"Puri","year":"2014","journal-title":"Eukaryot Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"55060","DOI":"10.1074\/jbc.M411031200","article-title":"The TRK1 potassium transporter is the critical effector for killing of Candida albicans by the cationic protein, Histatin 5","volume":"279","author":"Baev","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"13694","DOI":"10.1038\/s41598-019-50114-2","article-title":"Novel mitochondrial complex I-inhibiting peptides restrain NADH dehydrogenase activity","volume":"9","author":"Xue","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/AAC.01199-07","article-title":"The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding","volume":"52","author":"Jang","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_92","first-page":"1805793","article-title":"The Effects of Antimicrobial Peptide Nal-P-113 on Inhibiting Periodontal Pathogens and Improving Periodontal Status","volume":"2018","author":"Wang","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1034\/j.1600-051x.2002.290212.x","article-title":"Clinical and microbial evaluation of a histatin-containing mouthrinse in humans with experimental gingivitis: A phase-2 multi-center study","volume":"29","author":"Paquette","year":"2002","journal-title":"J. Clin. Periodontol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1034\/j.1600-051X.2002.291201.x","article-title":"Safety and clinical effects of topical histatin gels in humans with experimental gingivitis","volume":"29","author":"Paquette","year":"2002","journal-title":"J. Clin. Periodontol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1042\/bj20030779","article-title":"Human salivary MUC7 mucin peptides: Effect of size, charge and cysteine residues on antifungal activity","volume":"375","author":"Situ","year":"2003","journal-title":"Biochem. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-0711-6-14","article-title":"Factors affecting antimicrobial activity of MUC7 12-mer, a human salivary mucin-derived peptide","volume":"6","author":"Wei","year":"2007","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00189377","article-title":"Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin","volume":"182","author":"Bellamy","year":"1993","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.peptides.2016.04.005","article-title":"Anti-infective efficacy of the lactoferrin-derived antimicrobial peptide HLR1r","volume":"81","author":"Bjorn","year":"2016","journal-title":"Peptides"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijantimicag.2010.08.020","article-title":"Fungicidal activity of human lactoferrin-derived peptides based on the antimicrobial alphabeta region","volume":"37","author":"Kondori","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"105399","DOI":"10.1016\/j.archoralbio.2022.105399","article-title":"Effect of human lactoferrin on Candida albicans infection and host response interactions in experimental oral candidiasis in mice","volume":"137","author":"Pawar","year":"2022","journal-title":"Arch. Oral Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1128\/AAC.44.12.3257-3263.2000","article-title":"Candidacidal activities of human lactoferrin peptides derived from the N terminus","volume":"44","author":"Lupetti","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/AAC.50.1.324-331.2006","article-title":"Distinct antifungal mechanisms: Beta-defensins require Candida albicans Ssa1 protein, while Trk1p mediates activity of cysteine-free cationic peptides","volume":"50","author":"Vylkova","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1107\/S0907444998011226","article-title":"Structure of recombinant human lactoferrin expressed in Aspergillus awamori","volume":"55","author":"Sun","year":"1999","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/CCM.0b013e3182741551","article-title":"A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis","volume":"41","author":"Guntupalli","year":"2013","journal-title":"Crit. Care Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"10745","DOI":"10.1074\/jbc.275.15.10745","article-title":"Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A","volume":"275","author":"Lugardon","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/BCJ20180801","article-title":"CGA-N9, an antimicrobial peptide derived from chromogranin A: Direct cell penetration of and endocytosis by Candida tropicalis","volume":"476","author":"Li","year":"2019","journal-title":"Biochem. J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1042\/BCJ20190483","article-title":"The chromogranin A-derived antifungal peptide CGA-N9 induces apoptosis in Candida tropicalis","volume":"476","author":"Li","year":"2019","journal-title":"Biochem. J."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1042\/BCJ20170894","article-title":"CGA-N12, a peptide derived from chromogranin A, promotes apoptosis of Candida tropicalis by attenuating mitochondrial functions","volume":"475","author":"Li","year":"2018","journal-title":"Biochem. J."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/BCJ20190678","article-title":"The antifungal peptide CGA-N12 inhibits cell wall synthesis of Candida tropicalis by interacting with KRE9","volume":"477","author":"Li","year":"2020","journal-title":"Biochem. J."},{"key":"ref_110","first-page":"62","article-title":"Curative effect of antifungal peptide CGA-N12 on mice systemically infected with Candida tropicalis","volume":"4","author":"Li","year":"2017","journal-title":"Prog. Vet. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e24258","DOI":"10.1002\/pep2.24258","article-title":"A short peptide derived from zebrafish AP-2 complex subunit mu-A AP2M1A354\u2013382 has antimicrobial activity against multi-drug resistant bacteria","volume":"114","author":"Gong","year":"2022","journal-title":"Pept. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.01790-09","article-title":"Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases","volume":"54","author":"Shin","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.febslet.2006.01.041","article-title":"Antifungal activity of synthetic peptide derived from halocidin, antimicrobial peptide from the tunicate, Halocynthia aurantium","volume":"580","author":"Jang","year":"2006","journal-title":"FEBS Lett."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1021\/bi5003585","article-title":"Combining experimental evidence and molecular dynamic simulations to understand the mechanism of action of the antimicrobial octapeptide jelleine-I","volume":"53","author":"Cabrera","year":"2014","journal-title":"Biochemistry"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbamem.2007.09.020","article-title":"Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: Pore formation mechanism in various lipid compositions","volume":"1778","author":"Park","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1007\/s00253-020-10701-0","article-title":"Anti-fungal properties and mechanisms of melittin","volume":"104","author":"Memariani","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1038\/jid.2014.75","article-title":"The protective effects of melittin on Propionibacterium acnes-induced inflammatory responses in vitro and in vivo","volume":"134","author":"Lee","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.micpath.2018.11.055","article-title":"Single dose eradication of extensively drug resistant Acinetobacter spp. In a mouse model of burn infection by melittin antimicrobial peptide","volume":"127","author":"Pashaei","year":"2019","journal-title":"Microb. Pathog."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s430-001-8025-x","article-title":"Cecropins, antibacterial peptides from insects and mammals, are potently fungicidal against Candida albicans","volume":"189","author":"Andra","year":"2001","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/iub.1527","article-title":"Cecropin A-induced apoptosis is regulated by ion balance and glutathione antioxidant system in Candida albicans","volume":"68","author":"Yun","year":"2016","journal-title":"IUBMB Life"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3389\/fmicb.2019.01595","article-title":"Cecropin A Alleviates Inflammation Through Modulating the Gut Microbiota of C57BL\/6 Mice With DSS-Induced IBD","volume":"10","author":"Zhai","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Battista, F., Oliva, R., Del Vecchio, P., Winter, R., and Petraccone, L. (2021). Insights into the Action Mechanism of the Antimicrobial Peptide Lasioglossin III. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062857"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/cbic.200900133","article-title":"Lasioglossins: Three novel antimicrobial peptides from the venom of the eusocial bee Lasioglossum laticeps (Hymenoptera: Halictidae)","volume":"10","author":"Cerovsky","year":"2009","journal-title":"ChemBioChem"},{"key":"ref_124","unstructured":"Miranda, A., Jouvensal, L., Vovelle, F., Bulet, P., and Daffre, S. (2009). Animal Toxins: State of the Art. Perspectives in Health and Biotechnology, UFMG."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"15301","DOI":"10.1016\/S0021-9258(19)49534-3","article-title":"Analysis of two novel classes of plant antifungal proteins from radish (Raphanus sativus L.) seeds","volume":"267","author":"Terras","year":"1992","journal-title":"J. Biol. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2958.2012.08017.x","article-title":"The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans","volume":"84","author":"Thevissen","year":"2012","journal-title":"Mol. Microbiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s11426-013-4884-y","article-title":"Comparison on effect of hydrophobicity on the antibacterial and antifungal activities of \u03b1-helical antimicrobial peptides","volume":"56","author":"Zhao","year":"2013","journal-title":"Sci. China Chem."},{"key":"ref_128","unstructured":"Pharma, D. (2022, September 19). XF-73 (Exeporfinium Chloride). Available online: https:\/\/www.destinypharma.com\/platform\/xf-73-exeporfinium-chloride\/."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1128\/AAC.49.4.1542-1552.2005","article-title":"Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells","volume":"49","author":"Maisch","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2217\/fmb.13.44","article-title":"Fungicidal photodynamic effect of a twofold positively charged porphyrin against Candida albicans planktonic cells and biofilms","volume":"8","author":"Gonzales","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bip.360290122","article-title":"The most highly amphiphilic alpha-helices include two amino acid segments in human immunodeficiency virus glycoprotein 41","volume":"29","author":"Eisenberg","year":"1990","journal-title":"Biopolymers"},{"key":"ref_132","unstructured":"Deslouches, B., Clancy, C., Nguyen, M., Cheng, S., and Mietzner, T. (2008, January 25\u201328). The antimicrobial peptide Wlbu2 is active against Candida spp. Cryptococcus neoformans and leading causes of bacterial sepsis. Proceedings of the Infectious Diseases Society of America 2008 Annual Meeting, Washington, DC, USA."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1099\/mic.0.26265-0","article-title":"Arming the enemy: The evolution of resistance to self-proteins","volume":"149","author":"Bell","year":"2003","journal-title":"Microbiology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1016\/j.biomaterials.2009.12.042","article-title":"The efficacy of self-assembled cationic antimicrobial peptide nanoparticles against Cryptococcus neoformans for the treatment of meningitis","volume":"31","author":"Wang","year":"2010","journal-title":"Biomaterials"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nnano.2009.153","article-title":"Self-assembled cationic peptide nanoparticles as an efficient antimicrobial agent","volume":"4","author":"Liu","year":"2009","journal-title":"Nat. Nanotechnol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.biomaterials.2010.11.054","article-title":"Synthetic cationic amphiphilic alpha-helical peptides as antimicrobial agents","volume":"32","author":"Wiradharma","year":"2011","journal-title":"Biomaterials"},{"key":"ref_137","unstructured":"NovaBiotics (2022, September 21). NovaBiotics Awarded \u00a31.8m in Small Business Research Innovation-Innovate UK Grant Funding to Advance Its Antifungal Drug Candidate, Novamycin. Available online: https:\/\/novabiotics.co.uk\/novabiotics-awarded-1-8m-in-small-business-research-innovation-innovate-uk-grant-funding-to-advance-its-antifungal-drug-candidate-novamycin\/."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12281-020-00369-4","article-title":"Combination Therapy for Invasive Fungal Infections","volume":"14","author":"Livengood","year":"2020","journal-title":"Curr. Fungal Infect. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Khalifa, H.O., Majima, H., Watanabe, A., and Kamei, K. (2021). In Vitro characterization of twenty-one antifungal combinations against echinocandin-resistant and -susceptible Candida glabrata. J. Fungi, 7.","DOI":"10.3390\/jof7020108"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/lam.13204","article-title":"Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms","volume":"69","author":"Kovacs","year":"2019","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"105901","DOI":"10.1016\/j.ijantimicag.2020.105901","article-title":"Colistin interacts synergistically with echinocandins against Candida auris","volume":"55","author":"Bidaud","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Chen, Y.L., Lehman, V.N., Averette, A.F., Perfect, J.R., and Heitman, J. (2013). Posaconazole exhibits in vitro and in vivo synergistic antifungal activity with caspofungin or FK506 against Candida albicans. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057672"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7883\/yoken.64.292","article-title":"Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis","volume":"64","author":"Kobayashi","year":"2011","journal-title":"Jpn. J. Infect. Dis."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/AAC.43.11.2635","article-title":"Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates","volume":"43","author":"Kuipers","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e0124022","DOI":"10.1128\/spectrum.01240-22","article-title":"Synergistic activity of the human Lactoferricin-derived peptide hLF1-11 in combination with caspofungin against Candida species","volume":"10","author":"Fais","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/AAC.47.1.262-267.2003","article-title":"Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species","volume":"47","author":"Lupetti","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1099\/jmm.0.2008\/001263-0","article-title":"Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative staphylococci and Candida albicans causing neonatal sepsis","volume":"57","author":"Venkatesh","year":"2008","journal-title":"J. Med. Microbiol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1128\/AAC.42.7.1587","article-title":"Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds","volume":"42","author":"Wakabayashi","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1348-0421.1996.tb01147.x","article-title":"Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents","volume":"40","author":"Wakabayashi","year":"1996","journal-title":"Microbiol. Immunol."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Rather, I.A., Sabir, J.S.M., Asseri, A.H., and Ali, S. (2022). Antifungal Activity of Human Cathelicidin LL-37, a Membrane Disrupting Peptide, by Triggering Oxidative Stress and Cell Cycle Arrest in Candida auris. J. Fungi, 8.","DOI":"10.3390\/jof8020204"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Zyrek, D., Wajda, A., Czechowicz, P., Nowicka, J., Jaskiewicz, M., Neubauer, D., and Kamysz, W. (2021). The Antimicrobial Activity of Omiganan Alone and In Combination against Candida Isolated from Vulvovaginal Candidiasis and Bloodstream Infections. Antibiotics, 10.","DOI":"10.3390\/antibiotics10081001"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/jac\/dkh181","article-title":"In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole","volume":"53","author":"Wei","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.peptides.2015.11.001","article-title":"The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms","volume":"75","author":"Vriens","year":"2016","journal-title":"Peptides"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"foaa020","DOI":"10.1093\/femsyr\/foaa020","article-title":"Combined effect of lasioglossin LL-III derivative with azoles against Candida albicans virulence factors: Biofilm formation, phospholipases, proteases and hemolytic activity","volume":"20","author":"Vankova","year":"2020","journal-title":"FEMS Yeast Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10989-020-10102-x","article-title":"Inhibitory Effects and Mechanism of the Combined Use of \u03b1-Helical Peptides HPRP-A1\/HPRP-A2 and Chlorhexidine Acetate against Bacterial and Fungal Biofilms","volume":"27","author":"Zhu","year":"2021","journal-title":"Int. J. Pept. Res. Ther."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/3\/789\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:44:06Z","timestamp":1760121846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/3\/789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":155,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["pharmaceutics15030789"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15030789","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]}}}